BACKGROUND:Worksites are potentially effective locations for obesity control because they provide opportunities for group intervention and social support. Studies are needed to identify effective interventions in these settings. OBJECTIVE: We examined the effects of a multicomponent lifestyle intervention on weight loss and prevention of regain in 4 worksites (2 intervention and 2 control sites). DESIGN:Overweight and obese employees (n = 133) enrolled in this pilot worksite-randomized controlled trial with a 0-6-mo weight-loss phase and a 6-12-mo structured weight-maintenance phase. The intervention combined recommendations to consume a reduced-energy, low-glycemic load, high-fiber diet with behavioral change education. Outcome measurements included changes in body weight and cardiometabolic risk factors. RESULTS: The mean ± SEM weight loss was substantial in intervention participants, whereas control subjects gained weight (-8.0 ± 0.7 compared with +0.9 ± 0.5 kg, respectively; P < 0.001), and 89% of participants completed the weight-loss phase. Intervention effects were not significant at the 0.05 level but would have been at the 0.10 level (P = 0.08) in a mixed model in which the worksite nested within group was a random factor. There were also significant improvements in cardiometabolic risk factors in intervention compared with control subjects regarding fasting total cholesterol, glucose, systolic blood pressure, and diastolic blood pressure (P ≤ 0.02 for each). No significant weight regain was observed in participants who enrolled in the structured weight-maintenance program (0.5 ± 0.7 kg; P = 0.65), and overweight and obese employees in intervention worksites who were not enrolled in the weight-loss program lost weight compared with subjects in control worksites (-1.3 ± 0.5 compared with +0.7 ± 0.2 kg, respectively; P = 0.02). CONCLUSION:Worksites can be effective for achieving clinically important reductions in body weight and improved cardiometabolic risk factors. This trial was registered at clinicaltrials.gov as NCT01470222.
RCT Entities:
BACKGROUND: Worksites are potentially effective locations for obesity control because they provide opportunities for group intervention and social support. Studies are needed to identify effective interventions in these settings. OBJECTIVE: We examined the effects of a multicomponent lifestyle intervention on weight loss and prevention of regain in 4 worksites (2 intervention and 2 control sites). DESIGN: Overweight and obese employees (n = 133) enrolled in this pilot worksite-randomized controlled trial with a 0-6-mo weight-loss phase and a 6-12-mo structured weight-maintenance phase. The intervention combined recommendations to consume a reduced-energy, low-glycemic load, high-fiber diet with behavioral change education. Outcome measurements included changes in body weight and cardiometabolic risk factors. RESULTS: The mean ± SEM weight loss was substantial in intervention participants, whereas control subjects gained weight (-8.0 ± 0.7 compared with +0.9 ± 0.5 kg, respectively; P < 0.001), and 89% of participants completed the weight-loss phase. Intervention effects were not significant at the 0.05 level but would have been at the 0.10 level (P = 0.08) in a mixed model in which the worksite nested within group was a random factor. There were also significant improvements in cardiometabolic risk factors in intervention compared with control subjects regarding fasting total cholesterol, glucose, systolic blood pressure, and diastolic blood pressure (P ≤ 0.02 for each). No significant weight regain was observed in participants who enrolled in the structured weight-maintenance program (0.5 ± 0.7 kg; P = 0.65), and overweight and obese employees in intervention worksites who were not enrolled in the weight-loss program lost weight compared with subjects in control worksites (-1.3 ± 0.5 compared with +0.7 ± 0.2 kg, respectively; P = 0.02). CONCLUSION: Worksites can be effective for achieving clinically important reductions in body weight and improved cardiometabolic risk factors. This trial was registered at clinicaltrials.gov as NCT01470222.
Authors: Emily B Kahn; Leigh T Ramsey; Ross C Brownson; Gregory W Heath; Elizabeth H Howze; Kenneth E Powell; Elaine J Stone; Mummy W Rajab; Phaedra Corso Journal: Am J Prev Med Date: 2002-05 Impact factor: 5.043
Authors: Nicholas P Hays; Gaston P Bathalon; Megan A McCrory; Ronenn Roubenoff; Ruth Lipman; Susan B Roberts Journal: Am J Clin Nutr Date: 2002-03 Impact factor: 7.045
Authors: Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young Journal: JAMA Date: 2003 Apr 23-30 Impact factor: 56.272
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Rena R Wing; Richard F Hamman; George A Bray; Linda Delahanty; Sharon L Edelstein; James O Hill; Edward S Horton; Mary A Hoskin; Andrea Kriska; John Lachin; Elizabeth J Mayer-Davis; Xavier Pi-Sunyer; Judith G Regensteiner; Beth Venditti; Judith Wylie-Rosett Journal: Obes Res Date: 2004-09
Authors: D J Jenkins; T M Wolever; R H Taylor; H Barker; H Fielden; J M Baldwin; A C Bowling; H C Newman; A L Jenkins; D V Goff Journal: Am J Clin Nutr Date: 1981-03 Impact factor: 7.045
Authors: Gary D Foster; Holly R Wyatt; James O Hill; Brian G McGuckin; Carrie Brill; B Selma Mohammed; Philippe O Szapary; Daniel J Rader; Joel S Edman; Samuel Klein Journal: N Engl J Med Date: 2003-05-22 Impact factor: 91.245
Authors: Mohammad Y Yakoob; Renata Micha; Shahab Khatibzadeh; Gitanjali M Singh; Peilin Shi; Habibul Ahsan; Nagalla Balakrishna; Ginnela N V Brahmam; Yu Chen; Ashkan Afshin; Saman Fahimi; Goodarz Danaei; John W Powles; Majid Ezzati; Dariush Mozaffarian Journal: Am J Public Health Date: 2016-10-13 Impact factor: 9.308
Authors: Claire Townsend Ing; Robin E S Miyamoto; Rui Fang; Mapuana Antonio; Diane Paloma; Kathryn L Braun; Joseph Keawe'aimoku Kaholokula Journal: Health Educ Behav Date: 2018-03-04
Authors: Candace C Nelson; Gregory R Wagner; Alberto J Caban-Martinez; Orfeu M Buxton; Christopher T Kenwood; Erika L Sabbath; Dean M Hashimoto; Karen Hopcia; Jennifer Allen; Glorian Sorensen Journal: Am J Prev Med Date: 2014-03 Impact factor: 5.043
Authors: Luke Wolfenden; Sharni Goldman; Fiona G Stacey; Alice Grady; Melanie Kingsland; Christopher M Williams; John Wiggers; Andrew Milat; Chris Rissel; Adrian Bauman; Margaret M Farrell; France Légaré; Ali Ben Charif; Hervé Tchala Vignon Zomahoun; Rebecca K Hodder; Jannah Jones; Debbie Booth; Benjamin Parmenter; Tim Regan; Sze Lin Yoong Journal: Cochrane Database Syst Rev Date: 2018-11-14